Entero Therapeutics subsidiary receives default suspension, but no waiver

GridAI Technologies Corp.

On August 29, 2024, ImmunogenX received letter from Lender Mattress Liquidators suspending MAE Default under Credit Agreement.
Original Notice of Default was received on August 2, 2024, alleging Material Adverse Effect and accelerating all obligations.
Lender's suspension is not a waiver; all rights regarding enforcement of MAE Default are expressly reserved.
No principal amount or financial impact disclosed in filing; discussions are ongoing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.